Search research articles
Contact Us
Filters
Showing results (51-60 of 143) with videos related to
Page
of 15
Sort By:
Blood Advances
|
August 7, 2020
Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure
Joseph R Shaw, Na Li, Thomas Vanassche, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 8, 2024
Sexual functioning in men with haemophilia: Data from the haemophilia in the Netherlands-6 study
Tessa C M van Gastel, Lorynn Teela, Evelien P Mauser-Bunschoten, et al.
Thrombosis Research
|
November 12, 2017
Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study
Y Whitney Cheung, Stefano Barco, Ron A A Mathôt, et al.
Thrombosis Research
|
February 19, 2008
Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels
Willem M Lijfering, Michiel Coppens, Nic J G M Veeger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 9, 2022
Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHC
Wolfgang Miesbach, Fariba Baghaei, Ana Boban, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 26, 2020
Illness cognitions associated with health-related quality of life in young adult men with haemophilia
Perrine F Limperg, Heleen Maurice-Stam, Madelief R Heesterbeek, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 19, 2025
Evaluation of One-Stage Assays for the Monitoring of Recombinant Human Factor IX Padua Activity After Etranacogene Dezaparvovec Gene Therapy
Jan Astermark, Wolfgang Miesbach, Michiel Coppens, et al.
Blood
|
June 17, 2006
A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation
Michiel Coppens, Marlene H van de Poel, Ivan Bank, et al.
Journal of Thrombosis and Thrombolysis
|
December 18, 2012
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?
Brian Dale, John W Eikelboom, Jeffrey I Weitz, et al.
Hemasphere
|
February 10, 2022
Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A
Renske M T Ten Ham, Sikon M Walker, Marta O Soares, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 143) with videos related to
Sort By:
Page
of 15
Blood Advances
|
August 7, 2020
Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure
Joseph R Shaw, Na Li, Thomas Vanassche, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 8, 2024
Sexual functioning in men with haemophilia: Data from the haemophilia in the Netherlands-6 study
Tessa C M van Gastel, Lorynn Teela, Evelien P Mauser-Bunschoten, et al.
Thrombosis Research
|
November 12, 2017
Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study
Y Whitney Cheung, Stefano Barco, Ron A A Mathôt, et al.
Thrombosis Research
|
February 19, 2008
Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels
Willem M Lijfering, Michiel Coppens, Nic J G M Veeger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 9, 2022
Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHC
Wolfgang Miesbach, Fariba Baghaei, Ana Boban, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 26, 2020
Illness cognitions associated with health-related quality of life in young adult men with haemophilia
Perrine F Limperg, Heleen Maurice-Stam, Madelief R Heesterbeek, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 19, 2025
Evaluation of One-Stage Assays for the Monitoring of Recombinant Human Factor IX Padua Activity After Etranacogene Dezaparvovec Gene Therapy
Jan Astermark, Wolfgang Miesbach, Michiel Coppens, et al.
Blood
|
June 17, 2006
A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation
Michiel Coppens, Marlene H van de Poel, Ivan Bank, et al.
Journal of Thrombosis and Thrombolysis
|
December 18, 2012
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?
Brian Dale, John W Eikelboom, Jeffrey I Weitz, et al.
Hemasphere
|
February 10, 2022
Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A
Renske M T Ten Ham, Sikon M Walker, Marta O Soares, et al.
Page
of 15